Výsledky vyhledávání - "D Hernández-Flόrez"

FRI0385 Joint manifestations in patients diagnosed with idiopathic inflammatory myopathy: multicenter registry

Autor: Francisco Javier López-Longo, D. Hernández Flόrez, Raquel Almodóvar, T. Cobo, L. Lojo, P. García de la Peña, Carmen Larena, L. Valor, I. Llorente, Beatriz Joven, L. Ruiz, José Alfredo Martínez, Henry Moruno, Laura Nuño, Marianela García, Carmen Barbadillo

Publikováno v: Poster Presentations.

Background Idiopathic inflammatory myopathies (IIM) comprise a heterogeneous group of autoimmune conditions. Joint involvement can be considered to be part of the IIM systemic manifestations, together with a possible gastrointestinal, cardiovascular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6782cdbefea42e1f16ab00355c7bf888
https://doi.org/10.1136/annrheumdis-2017-eular.7051

Zobrazit plný text záznamu

FRI0448 Evaluation of suppurative hidradenitis in patients with chronic arthritis treated with full and tapered biological disease-modifying antirheumatic drugs

Autor: L Valor, D Hernández-Flόrez, T Río del, JG Ovalles B, J Martínez Barrio, I Janta, B Serrano, JC Nieto, M Correyero Plaza, L Garcia Montoya, C González, FJ Lόpez-Longo, I Monteagudo

Publikováno v: Poster Presentations.

Background Suppurative Hidradenitis (SH) is an inflammatory skin disease which often responds poorly to treatment. It is a disorder of the apocrine glands (axillary, inguinal and anogenital regions) that can result in infection, inflamed nodules, cys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::487db58fb027b43b2c2bac612491d2a0
https://doi.org/10.1136/annrheumdis-2017-eular.4737

Zobrazit plný text záznamu

AB0625 Autoantibody profile in patients diagnosed with idiopathic inflammatory myopathy: multicenter registry on inflammatory myositis from the rheumatology society in madrid, spain

Autor: Lynnette A. Ruiz, Laura Nuño, I. Llorente, P. García de la Peña, L. Valor, Carmen Larena, Carmen Barbadillo, Marianela García, Beatriz Joven, D. Hernández Flόrez, José Alfredo Martínez, Henry Moruno, T. Cobo, Raquel Almodóvar, L. Lojo, Francisco Javier López-Longo

Publikováno v: Abstracts Accepted for Publication.

Background Inflammatory myopathies (IIM) are a heterogeneous group of autoimmune rheumatic diseases characterized by muscle inflammation and progressive weakness. They include any kind of primary inflammatory muscle disease that is not otherwise bett

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f50a50d5e663bf3fefbf4ab43e089d40
https://doi.org/10.1136/annrheumdis-2017-eular.7050

Zobrazit plný text záznamu

AB0026 B-Cell Profile in RA Patients Treated with Two Different Biological Therapeutic Targets: Anti-TNF and Anti-Il6r. A Cross-Sectional Study

Autor: D. Hernández Flόrez, L. Valor, I. de la Torre, T. del Río, L. Martinez, E. Naredo, C. González, J. Lopez-Longo, I. Monteagudo, M. Montoro, L. Carreño Perez

Publikováno v: Annals of the Rheumatic Diseases. 73:812.2-812

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e38b04f9167f7de7a271f240fa20e682
https://doi.org/10.1136/annrheumdis-2014-eular.3157

Zobrazit plný text záznamu

SAT0340 Infliximab Levels and Anti-Infliximab Antibodies Comparison between Two Comercial ELISA Versions in Patients with Ankylosing Spondylitis

Autor: Javier López-Longo, Cristina González, Juan Carlos Nieto, I. de la Torre, L. Valor, T. del Río, María Montoro, Esperanza Naredo, L. Carreño Pérez, Indalecio Monteagudo, L. Martinez, D. Hernández Flόrez

Publikováno v: Annals of the Rheumatic Diseases. 73:715.2-716

Background Ankylosing spondylitis (AS) is a chronic inflammatory disease which can result in invalidating deformities of the joints and spine at an early age. The introduction of tumor necrosis factor (TNF) blocking agents has changed the treatment o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40be78b12dd733c815a697d1953c344b
https://doi.org/10.1136/annrheumdis-2014-eular.3274

Zobrazit plný text záznamu

AB0027 B-Cell Activating Factor (BAFF) Binding Receptors (BBR) on B Cells: Characterization in Patients with Rheumatoid Arthritis (RA) Receiving Biological Therapies: Anti-TNF, Anti-Il6r and Anti-Ctla4: A Longitudinal Study

Autor: D. Hernández Flόrez, L. Martinez, Indalecio Monteagudo, A. Gallego, M. Salvat, Esperanza Naredo, L. Valor, C. A. Gonzalez, María Montoro, I. de la Torre, T. del Río, E. Chamizo, L. Carreño Pérez, Javier López-Longo

Publikováno v: Annals of the Rheumatic Diseases. 73:812.3-813

Background The treatment of rheumatoid arthritis (RA) has improved in the last years because of both: an increased understanding of its pathogenesis and the use of biological therapies. It is well known that B cells play a pivotal role in the develop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50bc619283ab00435515e3b91ba41dd1
https://doi.org/10.1136/annrheumdis-2014-eular.3191

Zobrazit plný text záznamu

AB0396 Infliximab and Adalimumab Levels and Antidrug Antibodies Detection in Patients with Rheumatoid Arthritis (RA): an Interlaboratory Comparison Using A Commercial ELISA Assay

Autor: I. de la Torre, J. Lόpez-Longo, D. Hernández Flόrez, Juan F Rosas, L. Valor, L. Carreño Pérez, Esperanza Naredo, Indalecio Monteagudo, F. Llinares, Cristina González, María Montoro, J. Yaque

Publikováno v: Annals of the Rheumatic Diseases. 73:937-937

Background The assessment of biological drug levels and immunogenicity might be essential in terms of a more effective and rational use of biological therapies and it is dependent upon the establishment of efficient standardized assays or a consensus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62f820a13ca1b06c1331c76d824f7d41
https://doi.org/10.1136/annrheumdis-2014-eular.3290

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání